Suzhou Fushilai Pharmaceutical Co. Ltd. Net Asset Momentum
Suzhou Fushilai Pharmaceutical Co. Ltd. net asset momentum. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) recorded a net asset momentum of -3.0% as of December 2024, with net assets of CN¥1.89 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See net assets of Suzhou Fushilai Pharmaceutical Co. Ltd. for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Net asset momentum of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. This chart tracks Suzhou Fushilai Pharmaceutical Co. Ltd.'s year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -3.0%, with net assets of CN¥1.89 Billion CNY as of December 2024. Check Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Suzhou Fushilai Pharmaceutical Co. Ltd. Net Asset Momentum by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. net asset momentum by year from 2019 to 2024. The table below shows the complete annual net asset history for Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 301258 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.89 Billion | CN¥2.09 Billion | CN¥200.84 Million | ▼ -3.0% |
| 2023 | CN¥1.95 Billion | CN¥2.12 Billion | CN¥170.45 Million | ▲ +3.1% |
| 2022 | CN¥1.89 Billion | CN¥2.10 Billion | CN¥211.75 Million | ▲ +154.0% |
| 2021 | CN¥742.84 Million | CN¥970.31 Million | CN¥227.47 Million | ▲ +19.3% |
| 2020 | CN¥622.64 Million | CN¥788.25 Million | CN¥165.61 Million | ▲ +7.0% |
| 2019 | CN¥581.96 Million | CN¥751.44 Million | CN¥169.48 Million | — |